Avanafil is a product currently being produced by the company Vivus, Inc. Its eventual goal will be to treat erectile dysfunction in men.
The science behind Avanafil will be to operate in a similar way as other prescription drugs like Cialis, Viagra, and Levitra as it tries to block a protein that itself blocks blood vessels from expanding. If these blood vessels in the penis are allowed to expand, the theory is that blood can flow into the caverns of the penis, creating an erection.
Avanafil has been reported to have minimal side effects so far. The reason for this is because Avanafil may stay in the blood for less time than its competitors. It also has been reported that it can begin to work within 30 minutes, thereby decreasing the time a man must prepare himself to engage in sexual activity.
The latest news on Avanafil at the time of this review is that it may be metabolizing very quickly, allowing men to take one pill in the morning as well as another in the evening. The latest reports were announced on January 12th, 2011.
Positives:
May offer another option for men with erectile dysfunction
Negatives:
Not yet released
Upon release, will still only be available with a prescription (as of time of review)
Ingredients:
(S)-2-(2-Hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[(2-pyrimidinylmethyl)carbamoyl]pyrimidine;4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide;Avanafil
